120 related articles for article (PubMed ID: 24315309)
1. Enhanced antitumor efficacy of integrin-targeted oncolytic adenovirus AxdAdB3-F/RGD on bladder cancer.
Wang H; Cai Z; Yang F; Luo J; Satoh M; Arai Y; Li D
Urology; 2014 Feb; 83(2):508.e13-9. PubMed ID: 24315309
[TBL] [Abstract][Full Text] [Related]
2. E1A, E1B double-restricted adenovirus with RGD-fiber modification exhibits enhanced oncolysis for CAR-deficient biliary cancers.
Wakayama M; Abei M; Kawashima R; Seo E; Fukuda K; Ugai H; Murata T; Tanaka N; Hyodo I; Hamada H; Yokoyama KK
Clin Cancer Res; 2007 May; 13(10):3043-50. PubMed ID: 17505007
[TBL] [Abstract][Full Text] [Related]
3. Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice.
Shen YH; Yang F; Wang H; Cai ZJ; Xu YP; Zhao A; Su Y; Zhang G; Zhu SX
PLoS One; 2016; 11(1):e0147173. PubMed ID: 26799485
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic viral therapy by bladder instillation using an E1A, E1B double-restricted adenovirus in an orthotopic bladder cancer model.
Wang H; Satoh M; Abe H; Sunamura M; Moriya T; Ishidoya S; Saito S; Hamada H; Arai Y
Urology; 2006 Sep; 68(3):674-81. PubMed ID: 16979729
[TBL] [Abstract][Full Text] [Related]
5. RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells.
Yang Y; Xu H; Shen J; Yang Y; Wu S; Xiao J; Xu Y; Liu XY; Chu L
Cell Death Dis; 2015 May; 6(5):e1760. PubMed ID: 25973680
[TBL] [Abstract][Full Text] [Related]
6. Effective gene transfer to human melanomas via integrin-targeted adenoviral vectors.
Nakamura T; Sato K; Hamada H
Hum Gene Ther; 2002 Mar; 13(5):613-26. PubMed ID: 11916485
[TBL] [Abstract][Full Text] [Related]
7. [Double-mutated oncolytic adenovirus combined with gemcitabine for treating an orthotopic nude mouse model of bladder cancer].
Wang H; Liu Z; Wang ZP; Li FY; Zhao Y; Chen GP; Li DC
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):412-7. PubMed ID: 24119899
[TBL] [Abstract][Full Text] [Related]
8. Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.
Hiwasa K; Nagaya H; Terao S; Acharya B; Hamada K; Mizuguchi H; Gotoh A
Anticancer Res; 2012 Aug; 32(8):3137-40. PubMed ID: 22843884
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer.
Dehari H; Ito Y; Nakamura T; Kobune M; Sasaki K; Yonekura N; Kohama G; Hamada H
Cancer Gene Ther; 2003 Jan; 10(1):75-85. PubMed ID: 12489031
[TBL] [Abstract][Full Text] [Related]
10. Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 ('Telomelysin-RGD').
Taki M; Kagawa S; Nishizaki M; Mizuguchi H; Hayakawa T; Kyo S; Nagai K; Urata Y; Tanaka N; Fujiwara T
Oncogene; 2005 Apr; 24(19):3130-40. PubMed ID: 15735729
[TBL] [Abstract][Full Text] [Related]
11. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer.
Fukuda K; Abei M; Ugai H; Kawashima R; Seo E; Wakayama M; Murata T; Endo S; Hamada H; Hyodo I; Yokoyama KK
Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710
[TBL] [Abstract][Full Text] [Related]
12. E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer.
Fukuda K; Abei M; Ugai H; Seo E; Wakayama M; Murata T; Todoroki T; Tanaka N; Hamada H; Yokoyama KK
Cancer Res; 2003 Aug; 63(15):4434-40. PubMed ID: 12907616
[TBL] [Abstract][Full Text] [Related]
13. E1A, E1B double-restricted adenovirus enhances the cytotoxicity and antitumor activity of gemcitabine to renal cell carcinoma.
Wang H; Satoh M; Chen GP; Li DC; Hamada H; Arai Y
Chin Med J (Engl); 2011 Apr; 124(7):1082-7. PubMed ID: 21542972
[TBL] [Abstract][Full Text] [Related]
14. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
[TBL] [Abstract][Full Text] [Related]
15. The alphavbeta5 integrin of hematopoietic and nonhematopoietic cells is a transduction receptor of RGD-4C fiber-modified adenoviruses.
Nagel H; Maag S; Tassis A; Nestlé FO; Greber UF; Hemmi S
Gene Ther; 2003 Sep; 10(19):1643-53. PubMed ID: 12923563
[TBL] [Abstract][Full Text] [Related]
16. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway.
Fueyo J; Alemany R; Gomez-Manzano C; Fuller GN; Khan A; Conrad CA; Liu TJ; Jiang H; Lemoine MG; Suzuki K; Sawaya R; Curiel DT; Yung WK; Lang FF
J Natl Cancer Inst; 2003 May; 95(9):652-60. PubMed ID: 12734316
[TBL] [Abstract][Full Text] [Related]
17. PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability.
Eto Y; Gao JQ; Sekiguchi F; Kurachi S; Katayama K; Maeda M; Kawasaki K; Mizuguchi H; Hayakawa T; Tsutsumi Y; Mayumi T; Nakagawa S
J Gene Med; 2005 May; 7(5):604-12. PubMed ID: 15543536
[TBL] [Abstract][Full Text] [Related]
18. Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo.
Wang DG; Zhao MJ; Liu YQ; Liu XW; Niu HT; Song YF; Tian YX
Oncotarget; 2016 Nov; 7(44):71710-71717. PubMed ID: 27687590
[TBL] [Abstract][Full Text] [Related]
19. Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells.
Cripe TP; Dunphy EJ; Holub AD; Saini A; Vasi NH; Mahller YY; Collins MH; Snyder JD; Krasnykh V; Curiel DT; Wickham TJ; DeGregori J; Bergelson JM; Currier MA
Cancer Res; 2001 Apr; 61(7):2953-60. PubMed ID: 11306473
[TBL] [Abstract][Full Text] [Related]
20. Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.
Lamfers ML; Grill J; Dirven CM; Van Beusechem VW; Geoerger B; Van Den Berg J; Alemany R; Fueyo J; Curiel DT; Vassal G; Pinedo HM; Vandertop WP; Gerritsen WR
Cancer Res; 2002 Oct; 62(20):5736-42. PubMed ID: 12384532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]